phone Help-contact

Hodowla genetycznie zmodyfikowanych świń na narządy dla ludzi

EN_01640053_0126
Hodowla genetycznie zmodyfikowanych świń na narządy dla ludzi
  • 30,00 EUR

    Making print for private purpose, storage in computer memory, no distribution rights.

  • 40,00 EUR

    Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 75,00 EUR

    Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 90,00 EUR

    Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices
Contact us to calculate price for another use. Prices only for online sales.
TO GO WITH AFP STORY by Ulysee BELLIER "A US farm breeds pigs for human kidney transplants"
Nuclear Transfer Scientist, Anneke Walters, and Head of Cell Biology and Nuclear Transfer, Todd Vaught (R), sort through oocytes as they prepare them for an injection of genetic modifications at the Revivicor Laboratories in Blacksburg, Virginia on November 22, 2024. On a farm in the southern US state of Virginia, David Ayares and his research teams are breeding genetically modified pigs to transplant their organs into human patients. Revivicor, the biotech company Ayares leads, is at the forefront of xenotransplantation research -- the implantation of animal organs into humans -- which aims to solve a chronic organ shortage that has thousands of Americans dying each year. It was on this farm that Revivicor bred a pig whose kidney was recently transplanted into patient Towana Looney, according to an announcement made Tuesday by a New York hospital. (Photo by Andrew Caballero-Reynolds / AFP)
2024-11-21
ANDREW CABALLERO-REYNOLDS/AFP/East News
AFP
ANDREW CABALLERO-REYNOLDS
AFP_36N63F7
3,92MB
68cm x 45cm by 300dpi
2024, 22, A, ACCORDING, AFP, AIMS, AMERICANS, AN, AND, ANDREW, ANIMAL, ANNEKE, ANNOUNCEMENT, ARE, AS, AT, ayares, BIOLOGY, BIOTECH, BLACKSBURG, BRED, BREEDING, BY, CABALLERO-REYNOLDS, CELL, CHRONIC, COMPANY, DAVID, DYING, EACH, FARM, FOR, FOREFRONT, GENETIC, GENETICALLY, HAS, HEAD, HIS, HORIZONTAL, HOSPITAL, HUMAN, HUMANS, IMPLANTATION, IN, INJECTION, INTO, IS, IT, KIDNEY, LABORATORIES, LEADS, LOONEY, MADE, MODIFICATIONS, MODIFIED, NEW, NOVEMBER, NUCLEAR, OF, ON, OOCYTES, ORGAN, ORGANS, PATIENT, PATIENTS, PHOTO, PIG, PIGS, PREPARE, R, RECENTLY, RESEARCH, revivicor, SCIENCE, SCIENTIST, SHORTAGE, SOLVE, SORT, SOUTHERN, STATE, STATES, TEAMS, THAT, THE, THEIR, THEM, THEY, THIS, THOUSANDS, THROUGH, TO, TODD, TOWANA, TRANSFER, TRANSPLANT, TRANSPLANTED, TUESDAY, UNITED, US, VAUGHT, VIRGINIA, WALTERS, WAS, WHICH, WHOSE, XENOTRANSPLANTATION, YEAR, YORK,